NCT05619588

Brief Summary

The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
370

participants targeted

Target at P75+ for all trials

Timeline
65mo left

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Apr 2017Sep 2031

Study Start

First participant enrolled

April 4, 2017

Completed
5.6 years until next milestone

First Submitted

Initial submission to the registry

November 9, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 17, 2022

Completed
8.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2031

Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

13.8 years

First QC Date

November 9, 2022

Last Update Submit

February 26, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • AOFAS

    American Orthopedic Foot and Ankle Society Score (AOFAS) - Questionaire on pain (40 points), function (45 points) , and alignment (15 points) - 100 points score where 100 indicates a healthy midfoot

    Through study completion, an average of 1 per year

  • SMFA

    Short Musculoskeletal Function Assessment (SMFA) Score - 46 items Patient questionnaire divided into two sections: 34 questions on patients function assessment and 12 questions covering how bothered patients are by their symptoms where 1 indicates no problems/no difficulty/ not bothered and 5 indicates unable to do/symptoms all the time/being greatly bothered

    Through study completion, an average of 1 per year

  • SF-36

    Short Form Health Survey (SF-36) Score - 36-item patient-reproted survey of patient health - It consists on 8 scales: Physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. Each scale is transformed into a 0-100 scale where the lower score indicates the more disability and the higher score the lest disability

    Through study completion, an average of 1 per year

  • Sports Frequency Score

    Sports Frequency Score - Level of sport activity in leisure time where 0 indicates "no sports activity" and 4 indicates "professional level of sports activity, elite athlete

    Through study completion, an average of 1 per year

  • VAS Pain and Patient Satisfaction Score

    Visual Analog Scale (VAS) Score - Range of scores from 0-100 to indicate level of pain - Higher score indicates greater pain intensity

    Through study completion, an average of 1 per year

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who meet eligibility criteria - Patients who consent to participate to return for follow-up visits out to 10 years or longer

You may qualify if:

  • Patient is indicated for total ankle arthroplasty
  • Patient is skeletally mature
  • Patient is mentally capable of completing follow-up forms
  • Patient will be available for follow-up out to 10 years
  • Patient has been deemed a candidate for Ankle replacement by diagnosis of the investigator
  • Patient is willing and able to read and sign a study informed consent form

You may not qualify if:

  • Patient with excessive bone loss at the ankle joint site
  • Patient with severe osteoporosis
  • Patient with complete talar avascular necrosis
  • Patient with Active Osteomyelitis
  • Patient with Infection at the ankle site or infection at distant sites that could migrate to the ankle
  • Patient with Sepsis
  • Patient with Vascular deficiency in the involved limb
  • Patient with Neuromuscular inadequacy (e.g. Prior paralysis, fusion and or inadequate abductor strength)
  • Patient with Neuropathic joints
  • Patient with Neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing
  • Patient with Poor soft tissue coverage around the ankle
  • Patient with Charcot arthropathy
  • Previous ankle arthrodesis with excision of the malleoli
  • Excessive loads as caused by activity or patient weight - per investigator discretion
  • Skeletally immature patients (patient is less than 21 years if age at time of surgery)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mayo Clinic

Jacksonville, Florida, 32224, United States

RECRUITING

Duke Department of Orthopaedic Surgery

Durham, North Carolina, 27703, United States

RECRUITING

MeSH Terms

Conditions

Prosthesis Failure

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Samuel Adams, MD

    Duke Department of Orthopaedic Surgery

    PRINCIPAL INVESTIGATOR
  • Edward Haupt, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2022

First Posted

November 17, 2022

Study Start

April 4, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

September 30, 2031

Last Updated

February 27, 2025

Record last verified: 2025-02

Locations